These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6178538)

  • 61. [Prostatic acid phosphatase measured by amplified enzyme linked immunoassay. Its application to mass screening for prostatic tumor and monitoring the clinical course of prostatic cancer patients].
    Yamanaka H; Yuasa H; Natori E; Imai K; Mashimo T
    Rinsho Byori; 1987 Oct; 35(10):1154-8. PubMed ID: 3325662
    [No Abstract]   [Full Text] [Related]  

  • 62. Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase.
    Foti AG; Cooper JF; Herschman H; Malvaez RR
    N Engl J Med; 1977 Dec; 297(25):1357-61. PubMed ID: 73133
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [What is the use of the radioimmunoassay of prostatic acid phosphatase?].
    Luckacs B; Cohen L; Coloby P; Gattegno B; Michel F; Agnes E; Roland J; Thibault P
    J Urol (Paris); 1985; 91(4):211-4. PubMed ID: 2410516
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunohistological demonstration of prostatic origin of malignant neoplasms.
    Nadji M; Tabei Z; Castro A; Morales AR
    Lancet; 1979 Mar; 1(8117):671-2. PubMed ID: 85907
    [No Abstract]   [Full Text] [Related]  

  • 65. Measurement of prostatic acid phosphatase in various cell lines.
    Foti AG; Herschman H; Cooper JF
    Natl Cancer Inst Monogr; 1978 Dec; (49):55-6. PubMed ID: 571048
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Serum prostatic acid phosphatase determination in prostatic diseases: a critical comparison of an enzymatic and a radioimmunologic assay.
    Van Cangh PJ; Opsomer R; De Nayer P
    J Urol; 1982 Dec; 128(6):1212-5. PubMed ID: 6185698
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
    Sharief FS; Mohler JL; Sharief Y; Li SS
    Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparative study of biochemical technique and radioimmunoassay for the measurement of serum prostatic acid phosphatase. Interest in the diagnosis of prostatic cancer?
    Canal P; Soula G
    Pathol Biol (Paris); 1982 Dec; 30(10):833-6. PubMed ID: 6185909
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immunological and clinical specificity of the immunochemical determination of prostatic acid phosphatase.
    Shaw LM; Yang N; Neat M; Croop W
    Ann N Y Acad Sci; 1982; 390():73-88. PubMed ID: 6178344
    [No Abstract]   [Full Text] [Related]  

  • 70. Evaluation of prostate specific acid phosphatase and prostate specific antigen in identification of prostatic cancer.
    Allhoff EP; Proppe KH; Chapman CM; Lin CW; Prout GR
    J Urol; 1983 Feb; 129(2):315-8. PubMed ID: 6339742
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Acid phosphatase in the bone marrow: diagnostic value in prostatic carcinoma].
    Tenaillon M; Billon B; Kelly A; Toppercer A; Elhilali MM
    J Urol (Paris); 1980; 86(2):107-10. PubMed ID: 7452042
    [No Abstract]   [Full Text] [Related]  

  • 72. The laboratory diagnosis of prostatic adenocarcinoma.
    Griffiths JC
    Crit Rev Clin Lab Sci; 1983; 19(3):187-204. PubMed ID: 6144453
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunodiagnosis by prostatic acid phosphatase to differentiate primary male breast cancer from metastatic prostate cancer.
    Kumar PP; Good RR; Newland JR
    J Natl Med Assoc; 1986 Aug; 78(8):782-4, 786. PubMed ID: 3531533
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The effects of various manipulations on serum phosphatase levels in benign disease.
    Greene FT; Thompson IM
    J Urol; 1974 Aug; 112(2):232-6. PubMed ID: 4135604
    [No Abstract]   [Full Text] [Related]  

  • 75. Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
    Vihko P; Kontturi M; Lukkarinen O; Vihko R
    J Urol; 1982 Oct; 128(4):739-41. PubMed ID: 6183458
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunohistochemistry of prostatic acid phosphatase.
    Yam LT; Janckila AJ; Lam WK; Li CY
    Prostate; 1981; 2(1):97-107. PubMed ID: 7024961
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The role of prostatic acid phosphatase in the investigation and treatment of adenocarcinoma of the prostate.
    Bruce AW; Mahan DE
    Ann N Y Acad Sci; 1982; 390():110-21. PubMed ID: 6953923
    [No Abstract]   [Full Text] [Related]  

  • 78. Rapid, fully automated radioimmunoassay of prostatic acid phosphatase in serum.
    Dass S; Bowen NL; Bagshawe KD
    Clin Chem; 1980 Oct; 26(11):1583-7. PubMed ID: 6158384
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Serial lectin affinity chromatography with concavalin A and wheat germ agglutinin demonstrates altered asparagine-linked sugar-chain structures of prostatic acid phosphatase in human prostate carcinoma.
    Yoshida KI; Honda M; Arai K; Hosoya Y; Moriguchi H; Sumi S; Ueda Y; Kitahara S
    J Chromatogr B Biomed Sci Appl; 1997 Aug; 695(2):439-43. PubMed ID: 9300882
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Role of acid phosphatase measurement in management of prostate cancer.
    Klein LA; Shapiro P
    Urology; 1981 Jun; 17(6):550-3. PubMed ID: 6166112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.